William Blair Investment Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-755,254
Closed -$6.69M 448
2017
Q4
$6.69M Sell
755,254
-354,390
-32% -$3.27M 0.03% 329
2017
Q3
$12.3M Buy
1,109,644
+321,345
+41% +$3.13M 0.04% 303
2017
Q2
$7.06M Buy
788,299
+74,502
+10% +$591K 0.03% 332
2017
Q1
$5.63M Sell
713,797
-52,945
-7% -$431K 0.02% 336
2016
Q4
$6.57M Buy
766,742
+374,786
+96% +$3.21M 0.03% 336
2016
Q3
$3.22M Buy
+391,956
New +$3.29M 0.01% 373

Other funds holding NEO

William Blair Investment Management's NEO Position: Q1 2018 in Review

William Blair Investment Management sold out of NeoGenomics (NEO) in Q1 2018, closing a stake of 755,254 shares — an estimated $6.69M sold.

William Blair Investment Management first reported a position in NEO in Q3 2016 and held it in 6 quarters. The position peaked at $12.3M in Q3 2017. 137 funds tracked by Wall St. Rank hold NEO as of Q1 2018.

  • William Blair Investment Management reported no remaining NeoGenomics position as of Q1 2018 after selling out during the quarter.
  • William Blair Investment Management sold 755,254 NeoGenomics shares in Q1 2018, an estimated $6.69M.
  • William Blair Investment Management first reported a position in NeoGenomics in Q3 2016 and held it in 6 quarters.
  • William Blair Investment Management's NeoGenomics position peaked at $12.3M in Q3 2017.
  • 137 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2018.

Based on William Blair Investment Management's 13F filing for Q1 2018, filed 14 May 2018.